1064
332
471
26
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T26559 | ACT-462206 | OX Receptor | |
ACT-462206 is an orally available Orexin 1/Orexin 2 receptor antagonist that crosses the blood-brain barrier.ACT-462206 is highly potent and can be used in studies of sleep and anxiety. | |||
T10242 | ACT-389949 | Others | |
ACT-389949 is a potent and selective agonist of formyl peptide receptor type 2 (FPR2)/Lipoxin A4 receptor (ALX), with an EC50 of 3 nM for FPR2/ALX internalization into monocytes. It has the potential for the treatment of... | |||
T14119 | ACT-678689 | Compound Example 1.53.4 | Hydroxylase |
ACT-678689 (Compound Example 1.53.4) (Compound Example 1.53.4) is a tryptophan hydroxylase (TPH) inhibitor with an IC50 of 8 nM[1]. | |||
T26557 | ACT-209905 | ACT 209905,ACT209905 | |
ACT-209905 is an agonist of S1P1 receptor. | |||
T9149 | 2BAct | 2B-Act,2B Act | PERK |
2BAct is a novel eif2b activator, preventing neurological defects caused by a chronic integrated stress response | |||
T14924 | Cenerimod | ACT-334441 | S1P Receptor |
Cenerimod (ACT-334441) is an orally active, selective, and potent sphingosine 1-phosphate receptor (S1P1) agonist (EC50: 1 nM).Cenerimod inhibits multiple S1P isoforms and can be used to study murine experimental autoimm... | |||
T3258 | Ponesimod | ACT-128800 | S1P Receptor , LPL Receptor |
Ponesimod (ACT-128800) is an orally available sphingosine-1-phosphate receptor 1 (S1PR1, S1P1) agonist with potential immunomodulating activity. | |||
T4020 | Cadazolid | ACT-179811 | Antibacterial , Antibiotic |
Cadazolid (ACT-179811) is an oxazolidinone-type antibiotic, with activity against gram-positive bacteria, including Clostridium difficile. | |||
T2058 | Palosuran | ACT-058362 | GPR |
Palosuran (ACT-058362) (ACT-058362) is a new potent and specific antagonist of the human UT receptor. | |||
T35623 | ACT-373898 | ||
ACT-373898 is a metabolite of the endothelin (ET) receptor type A (ETA) and ETBdual antagonist macitentan .1 1.Dingemanse, J., Sidharta, P.N., Maddrey, W.C., et al.Efficacy, safety and clinical pharmacology of macitentan... | |||
T2561 | Macitentan | ACT-064992 | Apoptosis , Endothelin Receptor |
Macitentan (ACT-064992) is an endothelin receptor antagonist that is used in the therapy of pulmonary arterial hypertension (PAH). | |||
T40542 | Sinbaglustat | ACT-519276,Sinbaglustat,OGT2378 | Transferase |
Sinbaglustat (OGT2378) (OGT2378) is a dual inhibitor of glucose ceramide synthetase (GCS) and non-lysosomal glucose ceramidase (GBA2).Sinbaglustat is an orally administered N-alkyl iminosugar that crosses the blood-brain... | |||
T7817 | Aprocitentan | ACT-132577 | Endothelin Receptor |
Aprocitentan (ACT-132577) is ETA and ETB antagonist . | |||
T2613 | Almorexant | ACT 078573 | OX Receptor |
Almorexant (ACT 078573) is a potent and competitive dual orexin 1 receptor (OX1)/orexin 2 receptor (OX2) antagonist with Ki values of 1.3 and 0.17 nM for OX1 and OX2, respectively. | |||
T14120 | ACT-709478 | Others | |
ACT-709478 is a potent, selective T-type calcium channel blocker that is orally active and capable of penetrating the brain. It is currently utilized in research focusing on generalized epilepsies[1]. | |||
T4689 | Palosuran hydrochloride 540769-28-6(free base) | ACT-058362 hydrochloride | GPR |
Palosuran hydrochloride 540769-28-6(free base)(ACT-058362 hydrochloride) is a new potent and specific antagonist of the human UT receptor with an IC50 of 3.6±0.2 nM. | |||
T70616 | ACT-672125 | ||
ACT-672125 is a Potent CXCR3 Antagonist with Therapeutic Potential in Autoimmune Diseases. ACT-672125 showed good physicochemical properties and safety profile. In a proof-of-mechanism model of lung inflammation, ACT-672... | |||
T70475 | ACT-280778 | ||
ACT-280778 is a potent L/T calcium channel blocker. | |||
T3216 | Selexipag | NS-304,ACT-293987,Uptravi | Others , Prostaglandin Receptor |
Selexipag (ACT-293987)(NS-304) is prostacyclin receptor agonist that causes vasodilation in pulmonary vasculature and is used in the therapy of pulmonary arterial hypertension (PAH). | |||
T39665 | ACT-1004-1239 | ||
ACT-1004-1239 is a highly potent and selective antagonist of CXCR7, which can be administered orally. It exhibits an impressive inhibitory concentration (IC50) value of 3.2 nM. | |||
T14123 | ACT 178882 | RAAS | |
ACT 178882 is a new Renin inhibitor (IC50: 1.4 nM). | |||
T21850 | ACT 335827 | ||
ACT-335827 is an orally available, brain-penetrant orexin type 1 receptor selective antagonist. ACT-33582 acts on OXR1 and OXR2 with IC 50 values of 6 nM and 417 nM, respectively. ACT-33582 can be used in studies related... | |||
T3520 | Setipiprant | KYTH-105,ACT-129968 | GPR , Prostaglandin Receptor |
Setipiprant (ACT-129968) is an orally available, selective CRTH2 antagonist (IC50: 6.0 nM). CRTH2 is a G protein-coupled receptor for prostaglandin (PGD2). PGD2 is produced by the mast cells and is a key mediator in vari... | |||
T26558 | ACT-387042 | ACT387042 | |
ACT-387042 is a Bacterial Topoisomerase Inhibitor, it has broad-spectrum activity against Gram-positive and Gram-negative bacteria. | |||
T23625 | ACT-451840 | ACT451840 | |
ACT-451840 is a drug of antimalarial activity. It has effective activity against sensitive and resistant Plasmodium falciparum strains. | |||
T71363 | ACT-281959 | ||
ACT-281959, a prodrug of ACT-246475, is a novel potent and selective P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than Clopidogrel. ACT-281959 showed antithrombotic efficacy after oral administr... | |||
T73148 | ACT-777991 | ||
ACT-777991 is an orally active, selective CXCR3 antagonist with demonstrated stability in microsomes and hepatocytes across various animal models. This compound effectively inhibits the migration of activated T cells tow... | |||
T63761 | ACT-660602 | ||
ACT-660602 is an orally active chemokine receptor CXCR3 antagonist (IC50: 204 nM). ACT-660602 inhibits T cell migration and has shown significant effects in an in vivo model of acute lung injury. ACT-660602 can be used t... | |||
T73100 | ACT-606559 | ||
ACT-606559, a metabolite of ACT451840, is a novel chemical compound exhibiting antimalarial properties. It is utilized in malaria research. | |||
T77442 | Glenzocimab | ACT017 | Others |
Glenzocimab (ACT017) is a Fab fragment of a humanized anti-GPVI monoclonal antibody. Glenzocimab demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model. Glenzocimab has been studied ... | |||
T24478 | MK-8141 | MK 8141,ACT 077825,ACT077825,ACT-077825 | |
MK-8141 is a renin inhibitor. It displays some antihypertensive efficacy in hypertensive patients. | |||
T10351 | Aprocitentan D4 | ACT-132577 D4 | Others |
Aprocitentan D4 (ACT-132577 D4) is a deuterium-labeled Aprocitentan. Aprocitentan is a major and pharmacologically active metabolite of Macitentan. Aprocitentan is a dual ETA/ETB antagonist (IC50s: 3.4 nM and 987 nM; pA2... | |||
T11934 | Macitentan-d4 | Macitentan D4,ACT-064992 D4 | Endothelin Receptor |
Macitentan-d4 (ACT-064992 D4) is a deuterated substitute for Macitentan and can be used as a dual antagonist of the non-peptides ETA and ETB (endothelin receptor).Macitentan-d4 is less toxic than Macitentan, has a longer... | |||
T6155 | Almorexant hydrochloride | ACT-078573 hydrochloride,Almorexant HCl | OX Receptor |
Almorexant hydrochloride (ACT-078573 hydrochloride) is a potent and competitive dual orexin 1 receptor (OX1)/orexin 2 receptor (OX2) antagonist with Ki values of 1.3 and 0.17 nM for OX1 and OX2, respectively. | |||
T70474 | Gallamine | ||
Gallamine is an allosteric antagonist at muscarinic M2 acetylcholine receptors and an inhibitor of acetylcholinesterase. | |||
T70614 | SLR080811 HCl | ||
SLR080811 is a SphK inhibitor. Sphingosine-1-phosphate (S1P) is a ubiquitous, endogenous small molecule that is synthesized by two isoforms of sphingosine kinase (SphK1 and 2). Intervention of the S1P signaling pathway h... | |||
T71361 | CHS-828 nicotinate | ||
CHS-828 nicotinate is a CHS-828 salt with Nicotinic acid.. CHS-828 also known as GMX-1778, is a potent and selective NAMPT inhibitor. CHS-828 inhibits cellular synthesis of NAD. CHS 828 kill tumour cells by inhibiting ... | |||
T7744 | Piperaquine tetraphosphate tetrahydrate | Parasite | |
Piperaquine tetraphosphate tetrahydrate is a potent anti-parasites agent. | |||
T71362 | GCC-4401C free base | ||
GCC-4401C free base is a factor Xa inhibitor similar to rivaroxaban that is currently under development for venous thromboembolic disease (VTE). | |||
T7532 | Piperaquine | Parasite | |
Piperaquine is a bis-quinoline compound that inhibits the ex vivo growth of P. falciparum isolates from malaria-infected patients with IC50s ranging from 11.8-217.3 nM. | |||
TP1240 | Adrenocorticotropic Hormone (ACTH) (18-39), human TFA | CLIP (human) (TFA) | Others |
Adrenocorticotropic Hormone (ACTH) (18-39), human TFA (CLIP human TFA) is a corticotropinlike intermediate lobe peptide, it is is produced in the melanotrophs of the intermediate lobe of the pituitary. | |||
T40923 | Calcium lactate | Lactic acid calcium,Hemicalcium L-lactate,Lactate calcium,Conclyte calcium | Others |
Calcium lactate (Conclyte calcium) is used by the beverage industry as a source of calcium to fortify fruit juice. Calcium lactate facilitates the growth and phytic acid degradation of soybean sprouts. | |||
T77385 | Idactamab | INT-001 | |
Idactamab (INT-001) is a monoclonal antibody to the human amino acid transport protein ASCT2. | |||
T41287 | N-3-Oxo-octanoyl-L-homoserine lactone | Others | |
N-3-Oxo-octanoyl-L-homoserine lactone is a quorum-sensing signal molecule and an autoinducer for Agrobacterium. | |||
T60073 | Antimycobacterial agent-4 | 4-nitro-N-[4-(2-pyridyl)thiazol-2-yl]benzamide | Antibacterial |
Antimycobacterial agent-4 (4-nitro-N-[4-(2-pyridyl)thiazol-2-yl]benzamide) has antibacterial activity against Mycobacterium tuberculosis. | |||
T35795 | Lactisole | na-PMP | Taste receptor |
Lactisole (na-PMP) is an inhibitor of the glucose-sensing receptor | |||
T39924 | NF-κΒ activator 2 | NF-κB | |
NF-κΒ Activator 2 is a potent, orally active compound that efficiently activates NF-κB with an EC50 value of 1.58 μM. By enhancing NF-κB expression and activation, it induces SOD 2 synthesis, rendering it useful for amyo... | |||
T9612 | Antibacterial agent 27 | Anti-infection | |
Antibacterial agent 27 has potent anti-Candida activity. | |||
T9400 | KCNQ2/3 activator-1 | Others | |
KCNQ2/3 activator-1 is a Kv7.2/Kv7.3 (KCNQ2/3) potassium channel activator. | |||
T38476 | Metallo β-lactamase ligand 1 | Antibacterial | |
Metallo β-lactamase ligand 1 is an inhibitor of class B β-lactamase exhibiting antibacterial activities. |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T3S2007 | MRE-269 | MRE 269,ACT-333679,MRE269 | Prostaglandin Receptor |
MRE-269 (ACT-333679) is an orally available and long-acting prostacyclin receptor agonist prodrug. MRE-269(ACT-333679) is used for the treatment of pulmonary arterial hypertension. MRE-269(ACT-333679) is an active metabo... | |||
T1683 | Actriol | Epiestriol | Glucocorticoid Receptor |
Actriol (Epiestriol) is always used as Glucocorticoid Receptor agonist. | |||
T12045 | (-)-Hydroxycitric acid lactone | Garcinia lactone | ATP Citrate Lyase |
(-)-Hydroxycitric acid lactone (Garcinia lactone) is an anti-obesity agent.(-)-Hydroxycitric acid lactone was a potent inhibitor of ATP citrate lyase, which catalyzes the extramitochondrial cleavage of citrate to oxaloac... | |||
TN2539 | 1beta-Hydroxyalantolactone | IL Receptor , TNF | |
1beta-Hydroxyalantolactone is a small molecular compound isolated from the flower head of the medicinal plant giant British flower, which can inhibit the expression of TNF-α, IL-17 and IFN-γ in cells, promote the secreti... | |||
TN7212 | Acacetin-7-O-beta-D-galactopyranoside | Others | |
Acacetin-7-O-beta-D-galactopyranoside is a natural product found in Chrysanthemum indicum. | |||
T2S0410 | Euphorbia factor L1 | Euphorbiasteroid | Apoptosis , P-gp |
Euphorbia factor L1 (Euphorbiasteroid) can reduce Bcl-2, PI3K, AKT, and mTOR protein and mRNA levels, and up-regulate caspase-9 and caspase-3 protein levels. It induces autophagy and has anti-cancer, anti-adipogenic, ant... | |||
T4455 | DL-3-Phenyllactic acid | 3-Phenyllactic acid,2-Hydroxy-3-phenylpropanoic acid | Others , Endogenous Metabolite , Antibacterial |
3-Phenyllactic acid (PhLA) is a broad spectrum antimicrobial compound active against bacteria and fungi, DL-3-Phenyllactic acid (3-Phenyllactic acid) is a reagent involved in biological studies of nantioselectivity of li... | |||
TN1106 | Cyanidin-3-O-galactoside chloride | Ideain chloride | Antioxidant |
Cyanidin-3-O-galactoside chloride (Ideain chloride), extracted from hawthorn pericarp (EPHF), has antioxidant activity and can be used in obesity research. | |||
T7995 | α-Angelica lactone | Alpha-Angelica Lactone | Others , GST |
α-Angelica lactone has cardiotonic activity, may exert their effects by providing an increased contraction-dependent calcium pool to be released upon systolic depolarization. | |||
T5798 | Euphorbia Factor L2 | euphorbiafactor L2 | Apoptosis , NF-κB |
Euphorbia Factor L2 alleviates lipopolysaccharide-induced acute lung injury and inflammation through inhibits NF-κB activation. | |||
T8213 | Isolinderalactone | NOS , STAT | |
Isolinderalactone shows anti-inflammatory and anticancer capacity, and it exhibits moderate iNOS inhibitory activity, with the IC50 value of 0.30 uM. | |||
T2833 | Dehydrocostus Lactone | Epiligulyl oxide,(-)-Dehydrocostus lactone | IκB/IKK |
Dehydrocostus Lactone ((-)-Dehydrocostus lactone) shows anti-inflammatory, anti-ulcer, immunomodulatory and anti-tumor properties. | |||
T5220 | D-(-)-Lactic acid sodium | Sodium D-lactate | Others , Endogenous Metabolite |
D-(-)-Lactic acid sodium (Sodium D-lactate) is an organic acid. It is a chiral molecule, consisting of two optical isomers, L-lactic acid and D-lactic acid, with the L-isomer being the most common in living organisms. D-... | |||
TQ0284 | Hydroxyphenyllactic acid | Endogenous Metabolite , Antifungal | |
Hydroxyphenyllactic acid is an antifungal metabolite, fungi such as Lactobacillus sp. SK007. | |||
TJO2795 | D-Galacturonic acid hydrate | D-(+)-Galacturonic acid | Others , Endogenous Metabolite |
D-Galacturonic acid hydrate is used in the synthesis of N-(D-galacturonoyl) amino acids and dipeptides. | |||
T0591 | D-Galactose | D-(+)-Galactose,D-Galactopyranose,Alpha-D-galactose | Endogenous Metabolite |
D-Galactose (Alpha-D-galactose) is an aldohexose that exists naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins and is converted enzymatically into D-glucose for metabolism or polysaccharide... | |||
T4845 | L-Lactic acid | 2-HYDROXYPROPIONIC ACID,L-(+)-Lactic acid,(S)-2-Hydroxypropanoic acid | Endogenous Metabolite , Antibacterial , Antibiotic |
L-Lactic acid ((S)-2-Hydroxypropanoic acid) is a natural product produced by the anaerobic glycolysis of pyruvic acid. L-Lactic acid is a sensitive indicator of tissue hypoxia and can be used as a hemodynamic indicator i... | |||
TN6945 | Lactic acid | 2-hydroxypropanoic acid | Others |
Lactic acid (2-hydroxypropanoic acid) is a product of glycolysis and is widely found in nature.Lactic acid is produced in the body during hypoxia in contracted skeletal muscle and can be removed under fully aerobic condi... | |||
TQ0118 | Britannilactone | Desacetylinulicin | Others |
Britannilactone, extracted from the dried flower of Inula britannica L, significantly reduces melanin production in a dose-dependent manner (IC50: 15.5 uM). | |||
TN1635 | Euphorbia factor L8 | Others | |
Euphorbia factor L8 is a natural product | |||
TN1634 | Euphorbia factor L7b | Others | |
Euphorbia factor L7b,a natural product obtained from the herbs of Euphorbia pekinensis Rupr. | |||
T2829 | Isoalantolactone | (+)-Isoalantolactone,Isohelenin | Apoptosis , Endogenous Metabolite , Antibacterial , Autophagy |
Isoalantolactone (Isohelenin), isolated from Inula spp., can inhibit the growth of several types of Y cells. | |||
TN1637 | Eurycomalactone | Anti-infection , NF-κB | |
Eurycomalactone is a natural product isolated from Eurycoma longifolia Jack., acts as a potent NF-κB inhibitor( IC50 of 0.5 μM). Eurycomalactone inhibits protein synthesis, depletes cyclin D1, but does not affect TNFα-in... | |||
T35709 | N-acetyl-D-Lactosamine | N-Acetyllactosamine | Endogenous Metabolite |
N-acetyl-D-Lactosamine (N-Acetyllactosamine) is a disaccharide consisting of galactose and N-acetylglucose, which is an important component of various oligosaccharides and can be used as a starting material for the synth... | |||
T8085 | (-)-Corey lactone diol | Corey Lactone Diol | Others |
(-)-Corey lactone diol is a pharmaceutical intermediate | |||
T4942 | Galactose 1-phosphate Potassium salt | α-D-Galactose-1-phosphate Dipotassium Pentahydrate | Others , Endogenous Metabolite |
Galactose 1-phosphate Potassium salt (α-D-Galactose-1-phosphate Dipotassium Pentahydrate) is an intermediate in the galactose metabolism and nucleotide sugars metabolism pathways. | |||
T74862 | N-Lactoyl-Phenylalanine | N-Lactoylphenylalanine | Endogenous Metabolite |
N-Lactoyl-Phenylalanine (Lac-Phe) is a peptide coupling of lactic acid and phenylalanine, one of the metabolites in acute exercise, which can be used in the study of obesity and metabolism-related diseases. | |||
TN6796 | 2'-FUCOSYLLACTOSE | 2'-Fucosyl-D-lactose | Others |
2'-FUCOSYLLACTOSE (2'-Fucosyl-D-lactose) is a fucose-containing oligosaccharide. | |||
T5968 | DL-Homocysteine thiolactone hydrochloride | DL-Homocysteinethiolactone hydrochloride | Endogenous Metabolite |
DL-Homocysteine thiolactone hydrochloride (DL-Homocysteinethiolactone hydrochloride) is a cysteine derivative that binds to and induces conformational changes in various plasma proteins, slowing coagulation and inducing ... | |||
T25192 | Butyrolactone I | Olomoucin | CDK |
Butyrolactone I (Olomoucin) is an ATP-competitive inhibitor of CDK and cdc2 kinase family. Butyrolactone I shows antitumor effects in non-small cell lung, small cell lung, and prostate cancer cell lines. | |||
T125211 | Deoxy euphorbia factor L1 | Others | |
Deoxy euphorbia factor L1 is a natural product found in the seeds of Euphorbia lathyris L | |||
T5663 | α-Lactose | Lactose | Others |
α-Lactose is the major sugar present in milk and the main source of energy supplied to the newborn mammalian in its mother's milk. Lactose is also an important osmotic regulator of lactation. | |||
T5578 | L-Gulono-1,4-lactone | Others , Endogenous Metabolite | |
L-Gulono-1,4-lactone is a substrate of L-gulono-1,4-lactone oxidoreductase, which catalyzes the last step of the biosynthesis of L-ascorbic (Vitamin) C. | |||
TN1962 | Myricetin 3-O-galactoside | Myricetin 3-O-beta-D-galactopyranoside | NOS , Xanthine Oxidase |
Myricetin 3-O-galactoside (Myricetin 3-O-beta-D-galactopyranoside) can inhibit xanthine oxidase (xanthine oxidase; XO) activity, lipid peroxidation and scavenging free radicals. Myricetin 3-O-galactoside has many effects... | |||
T10941 | D-Ribonolactone | Endogenous Metabolite , Antibacterial | |
D-Ribonolactone is sugar lactone and an inhibitor of β-galactosidase of Escherichia coli (Ki : 26 Mm). | |||
T3902 | Atractylenolide III | ICodonolactone,8β-Hydroxyasterolide | Apoptosis |
Atractylenolide III (ICodonolactone) may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury. Atractylenolide III is a potential candidate for the treatment of human lung... | |||
TN1823 | Kaempferol 3-O-β-D-galactopyranoside | Kaempferol 3-O-beta-D-galactoside,Kaempferol-3-O-galactoside | Immunology/Inflammation related |
Kaempferol 3-O-β-D-galactopyranoside has antioxidant, anti-inflammatory and antinociceptive activities. | |||
T3S0156 | Atractyloside potassium salt | Atractyloside Dipotassium Salt | Others |
1. Atractyloside potassium salt (Atractyloside Dipotassium Salt) inhibits oxidative phosphorylation by blocking the transfer of adenosine nucleotides through the mitochondrial membrane. | |||
T3234 | Dihydroactinidiolide | R-(-)Dihydro actinidiolide | Others |
Dihydroactinidiolide (R-(-)Dihydro actinidiolide)is avolatileterpene. It has a sweet,tea-likeodorand is used as a fragrance. | |||
T5742 | Isodemethylwedelolactone | Isodemethylwedelolacton | Others |
Isodemethylwedelolactone (Isodemethylwedelolacton) is a natual product,has Clotting activity. | |||
T6528 | Gynostemma Extract | Gypenoside IX,Gypenoside,Gynostemma Pentaphyllum,Notoginsenoside Fd,Ginsenoside C-Mx1,Gynosaponin I | Others , Endogenous Metabolite |
Gynostemma Extract (Gypenoside IX) is a saponins extract derived from the Gynostemma pentaphyllum. | |||
T3666 | Atractylodin | Atractydin | Lipid |
Atractylodin (Atractydin) has high lipase inhibitory activity (IC5:39.12 μM); Atractylodin possesses strong repellency activities against T. castaneum adults (LD50: 1.83 μg/cm). The repellency of Atractylodin (0.63 μg/cm... | |||
T0434 | D-Glucuronic acid lactone | Glucuronolactone,D-Glucurone,Dicurone | Others , Endogenous Metabolite |
D-Glucuronic acid lactone (Dicurone) is a naturally occurring chemical that is an important structural component of nearly all connective tissues. Glucuronolactone is also found in many plant gums. | |||
T5S0689 | Demethylwedelolactone | Serine Protease | |
Demethylwedelolactone is a natural product isolated from Eclipta alba, has trypsin inhibitory effect an IC50 of 3.0 μM. it exerts anti-invasive growth effect on breast cancer cells. | |||
T3999 | D(+)-Galactosamine hydrochloride | D-Galactosamine HCl | Others |
D(+)-Galactosamine hydrochloride (D-Galactosamine HCl) hepatotoxicity is associated with endotoxin sensitivity and mediated by lymphoreticular cells in mice. | |||
T5S0168 | Atractylenolide II | 2-Atractylenolide,Asterolide | Apoptosis , ERK , p38 MAPK , Akt , STAT |
1. Atractylenolide II (2-Atractylenolide) has antimelanoma effect by inhibiting STAT3 signalling. 2. Atractylenolide II has cytotoxic/apoptotic effects may via p38 activation , ERK and Akt inactivation, p53 dependent. | |||
T8064 | Lactobionic acid | Others , Antibacterial | |
Lactobionic acid with antioxidant, antimicrobial and moisturizing propertie | |||
T1353 | DL-Mevalonolactone | Mevalonolactone | Others , Endogenous Metabolite |
DL-Mevalonolactone (Mevalonolactone) is very soluble in water and polar organic solvents. It exists in equilibrium with its lactone form, called mevalonolactone, that is formed by internal condensation of its terminal al... | |||
T5274 | D-(+)-Phenyllactic acid | D-3-Phenyllactic acid | Endogenous Metabolite , Antibacterial |
D-(+)-Phenyllactic acid (D-3-Phenyllactic acid), an antibacterial compound produced by Geotrichum candidum, effectively inhibits various Gram-positive and Gram-negative bacteria originating from humans and food products[... | |||
T8098 | γ-Hexalactone | γ-caprolactone | Others |
γ-Hexalactone (γ-caprolactone) belongs to the class of organic compounds known as gamma butyrolactones. Gamma butyrolactones are compounds containing a gamma butyrolactone moiety, which consists of an aliphatic five-memb... | |||
------------------------ More ------------------------ |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-06668 | Act d 8 Protein, Actinidia deliciosa, Recombinant | Actinidia deliciosa | P. pastoris (Yeast) |
Act d 8 Protein, Actinidia deliciosa, Recombinant is expressed in P. pastoris yeast expression system. The predicted molecular weight is 26.7 kDa. | |||
TMPK-00464 | OX40/TNFRSF4 Protein, Mouse, Recombinant (His & Avi), Biotinylated | Mouse | HEK293 Cells |
Tumor necrosis factor receptor superfamily, member 4 (TNFRSF4), also known as CD134 and OX40 receptor. OX40 is a secondary co-stimulatory immune checkpoint molecule, expressed after 24 to 72 hours following activation; i... | |||
TMPK-00168 | OX40/TNFRSF4 Protein, Human, Recombinant (aa 29-216, His & Avi), Biotinylated | Human | HEK293 Cells |
Tumor necrosis factor receptor superfamily, member 4 (TNFRSF4), also known as CD134 and OX40 receptor. OX40 is a secondary co-stimulatory immune checkpoint molecule, expressed after 24 to 72 hours following activation; i... | |||
TMPY-01423 | OX40/TNFRSF4 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
OX40/TNFRSF4 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 21.7 kDa and the accession number is P43489. | |||
TMPK-00169 | OX40/TNFRSF4 Protein (Primary Amine Labeling), Human, Recombinant (hFc), Biotinylated | Human | HEK293 Cells |
Tumor necrosis factor receptor superfamily, member 4 (TNFRSF4), also known as CD134 and OX40 receptor. OX40 is a secondary co-stimulatory immune checkpoint molecule, expressed after 24 to 72 hours following activation; i... | |||
TMPK-00167 | OX40/TNFRSF4 Protein, Human, Recombinant (His & Avi) | Human | HEK293 Cells |
Tumor necrosis factor receptor superfamily, member 4 (TNFRSF4), also known as CD134 and OX40 receptor. OX40 is a secondary co-stimulatory immune checkpoint molecule, expressed after 24 to 72 hours following activation; i... | |||
TMPK-00463 | OX40/TNFRSF4 Protein, Mouse, Recombinant (His & Avi) | Mouse | HEK293 Cells |
Tumor necrosis factor receptor superfamily, member 4 (TNFRSF4), also known as CD134 and OX40 receptor. OX40 is a secondary co-stimulatory immune checkpoint molecule, expressed after 24 to 72 hours following activation; i... | |||
TMPY-01303 | Serpin A3 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
SerpinA3, also known as Alpha 1-antichymotrypsin (AACT), is a plasma alpha globulin glycoprotein, and is a member of serpin superfamily of the serine protease inhibitors consisting of at least 35 members. SerpinA3 has be... | |||
TMPH-02567 | CCL4 Protein, Mouse, Recombinant (His) | Mouse | E. coli |
Monokine with inflammatory and chemokinetic properties. | |||
TMPY-04993 | OX40/TNFRSF4 Protein, Mouse, Recombinant (rFc) | Mouse | HEK293 Cells |
OX40/TNFRSF4 Protein, Mouse, Recombinant (rFc) is expressed in HEK293 mammalian cells with rFc tag. The predicted molecular weight is 47.3 kDa and the accession number is B1ASL3. | |||
TMPY-05020 | OX40/TNFRSF4 Protein, Mouse, Recombinant | Mouse | HEK293 Cells |
OX40/TNFRSF4 Protein, Mouse, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 22.1 kDa and the accession number is B1ASL3. | |||
TMPY-02368 | OX40/TNFRSF4 Protein, Mouse, Recombinant (hFc) | Mouse | HEK293 Cells |
OX40/TNFRSF4 Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 48.3 kDa and the accession number is B1ASL3. | |||
TMPY-06875 | OX40/TNFRSF4 Protein, Human, Recombinant (hFc & Avi), Biotinylated | Human | HEK293 Cells |
OX40/TNFRSF4 Protein, Human, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cells with hFc and Avi tag. The predicted molecular weight is 48.69 kDa and the accession number is NP_003318.1. | |||
TMPY-05339 | OX40/TNFRSF4 Protein, Human, Recombinant (hFc) | Human | HEK293 Cells |
OX40/TNFRSF4 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 46.9 kDa and the accession number is P43489. | |||
TMPY-06906 | OX40/TNFRSF4 Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 Cells |
OX40/TNFRSF4 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 23.34 kDa and the accession number is NP_003318.1. | |||
TMPY-00646 | CCL4 Protein, Human, Recombinant (His) | Human | P. pastoris (Yeast) |
CCL4 Protein, Human, Recombinant (His) is expressed in yeast with His tag. The predicted molecular weight is 9.2 kDa and the accession number is P13236. | |||
TMPY-05094 | Tissue Factor Protein, Cynomolgus, Recombinant (His) | Cynomolgus | HEK293 Cells |
Tissue Factor Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 26.4 kDa and the accession number is XP_005542723.1. | |||
TMPY-04778 | Prolactin Protein, Human, Recombinant (His) | Human | Baculovirus Insect Cells |
Prolactin Protein, Human, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 24.3 kDa and the accession number is P01236. | |||
TMPY-01727 | GLA/alpha-Galactosidase A Protein, Human, Recombinant (His) | Human | HEK293 Cells |
GLA/alpha-Galactosidase A Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 46.8 kDa and the accession number is P06280. | |||
TMPY-02047 | C-Reactive Protein Protein, Rat, Recombinant (His) | Rat | HEK293 Cells |
C-Reactive Protein Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24.6 kDa and the accession number is H6X2V1. | |||
TMPY-01053 | Prolactin Receptor Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Prolactin Receptor Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 26 kDa and the accession number is P16471-1. | |||
TMPY-00720 | Contactin 1 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Contactin 1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 110 kDa and the accession number is A0A024R104. | |||
TMPY-02530 | Tissue Factor Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Tissue Factor Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 26.2 kDa and the accession number is P13726. | |||
TMPY-01104 | Coagulation factor XI/F11 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Factor XI (plasma thromboplastin antecedent) is a plasma glycoprotein, and a zymogen acting as a serine protease which participates in blood coagulation as a catalyst in the conversion of factor IX to factor IXa in the p... | |||
TMPY-02185 | Coagulation factor XIII B/F13B Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Coagulation factor XIII B chain, also known as Fibrin-stabilizing factor B subunit, Protein-glutamine gamma-glutamyltransferase B chain, Transglutaminase B chain and F13B, is a secreted protein which contains 1 Sushi ... | |||
TMPY-03363 | C-Reactive Protein Protein, Human, Recombinant | Human | HEK293 Cells |
C-Reactive Protein Protein, Human, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 23 kDa and the accession number is P02741-1. | |||
TMPK-00114 | C-Reactive Protein /CRP Protein, Human, Recombinant (His) | Human | HEK293 Cells |
C-reactive protein (CRP) is a polypeptide molecule belonging to the family of pentraxins. CRP is synthesized primarily by the liver in response to certain pro-inflammatory cytokines. It plays an important role in innate ... | |||
TMPY-02424 | Prolactin Protein, Mouse, Recombinant (His) | Mouse | Baculovirus Insect Cells |
Prolactin Protein, Mouse, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 23.8 kDa and the accession number is Q9CPQ2. | |||
TMPJ-01471 | Activin A Protein, Human, Mouse, Rat, Cynomolgus, Rhesus, Recombinant | Human/Mouse/Rat | HEK293 Cells |
Activin and inhibin are two closely related protein complexes that have almost directly opposite biological effects. Activins, members of the TGF-beta superfamily, are disulfide-linked dimeric proteins originally purifi... | |||
TMPY-03221 | Intrinsic Factor Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Gastric intrinsic factor, also known as GIF, belongs to the of the cobalamin transport protein family. It is a glycoprotein produced by the parietal cells of the stomach. Gastric intrinsic factor plays a key role in the ... | |||
TMPY-03014 | Osteoactivin/GPNMB Protein, Mouse, Recombinant (His) | Mouse | HEK293 Cells |
Osteoactivin/GPNMB Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 54.9 kDa and the accession number is Q99P91. | |||
TMPY-01101 | Coagulation factor X/F10 Protein, Human, Recombinant (His) | Human | Baculovirus Insect Cells |
Coagulation factor X, also known as FX, F10, Eponym Stuart-Prower factor, and thrombokinase, is an enzyme of the coagulation cascade. It is one of the vitamin K-dependent serine proteases, and plays a crucial role in the... | |||
TMPY-01075 | Von Willebrand Factor/vWF Protein, Human, Recombinant (His) | Human | CHO Cells |
Von Willebrand Factor (VWF) is a multimeric glycoprotein involved in hemostasis in blood, binds receptors on the surface of platelets and in connective tissue, thereby mediating the adhesion of platelets to sites of vasc... | |||
TMPY-04921 | Complement factor B/CFB Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Complement factor B/CFB Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 84.5 kDa and the accession number is AAH04143.1. | |||
TMPY-02215 | Coagulation factor IX/F9 Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Coagulation factor IX/F9 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 50 kDa and the accession number is AAB59620.1. | |||
TMPH-00758 | EspK Protein, Mycobacterium tuberculosis, Recombinant (His & Myc) | Mycobacterium tuberculosis | E. coli |
May act as a chaperone that facilitates EspB secretion through an interaction with EccCb1. | |||
TMPH-00802 | VacA Protein, Helicobacter pylori, Recombinant (His & SUMO) | Helicobacter pylori | E. coli |
Induces vacuolation of eukaryotic cells. Causes ulceration and gastric lesions. vacA Protein, Helicobacter pylori, Recombinant (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted m... | |||
TMPH-00798 | HP-0175 Protein, Helicobacter pylori, Recombinant (GST) | Helicobacter pylori | E. coli |
N/A. HP-0175 Protein, Helicobacter pylori, Recombinant (GST) is expressed in E. coli expression system with N-GST tag. The predicted molecular weight is 58.8 kDa and the accession number is P56112. | |||
TMPH-00800 | UreA Protein, Helicobacter pylori, Recombinant (His) | Helicobacter pylori | P. pastoris (Yeast) |
Ammonia produced by ureolysis increases the gastric pH thereby providing an environment permissive for colonization of the stomach. | |||
TMPH-00019 | BlaNDM-1 Protein, Acinetobacter baumannii, Recombinant (His & SUMO) | Acinetobacter baumannii | E. coli |
BlaNDM-1 Protein, Acinetobacter baumannii, Recombinant (His & SUMO) is expressed in E. coli with N-terminal 6xHis-SUMO tag. The predicted molecular weight is 22.0 kDa. Accession number: F8UNN7 | |||
TMPH-03015 | MPT64 Protein, Mycobacterium tuberculosis, Recombinant (E. coli, His) | Mycobacterium tuberculosis | E. coli |
N/A. MPT64 Protein, Mycobacterium tuberculosis, Recombinant (E. coli, His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 26.4 kDa and the accession number is P9WIN9. | |||
TMPH-03013 | HRP1 Protein, Mycobacterium tuberculosis, Recombinant (His & Myc & SUMO) | Mycobacterium tuberculosis | E. coli |
Unlike some other CBS-domain containing proteins does not seem to bind AMP. | |||
TMPH-03017 | CYP51 Protein, Mycobacterium tuberculosis, Recombinant (His & Myc) | Mycobacterium tuberculosis | Baculovirus Insect Cells |
Its precise biological substrate is not known. Catalyzes C14-demethylation of lanosterol, 24,25-dihydrolanosterol and obtusifoliol which is critical for ergosterol biosynthesis. It transforms lanosterol into 4,4'-dimethy... | |||
TMPH-00006 | Actin-1 Protein, Absidia glauca, Recombinant (His & Myc) | Absidia glauca | E. coli |
Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. | |||
TMPH-00018 | 29 kDa outer membrane Protein, Acinetobacter baumannii, Recombinant (His & Myc & SUMO) | Acinetobacter baumannii | E. coli |
May be involved in transporting molecules across the outer membrane. | |||
TMPH-03122 | Prolactin Protein, Pig, Recombinant (His & SUMO) | Sus scrofa (Pig) | E. coli |
Prolactin acts primarily on the mammary gland by promoting lactation. Prolactin Protein, Pig, Recombinant (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 39... | |||
TMPY-02840 | Ubiquitin Activating Enzyme E1/UBA1 Protein, Human, Recombinant (His & GST) | Human | Baculovirus Insect Cells |
UBE1, also known as UBA1, belongs to the ubiquitin-activating E1 family. UBE1 gene complements an X-linked mouse temperature-sensitive defect in DNA synthesis, and thus may function in DNA repair. It is part of a gene cl... | |||
TMPH-00328 | Flagellin B(flaB) Protein, Campylobacter jejuni, Recombinant (His) | Campylobacter jejuni | E. coli |
Flagellin is the subunit protein which polymerizes to form the filaments of bacterial flagella. Flagellin B(flaB) Protein, Campylobacter jejuni, Recombinant (His) is expressed in E. coli expression system with C-6xHis ta... | |||
TMPH-00525 | DsDNA-binding protein A Protein, Enterobacteria phage T4, Recombinant (His & Myc) | Enterobacteria phage T4 | E. coli |
May play a role in transcription of several T4 genes. Binds double-stranded DNA and interacts preferentially with T4 late promoter regions. DsDNA-binding protein A Protein, Enterobacteria phage T4, Recombinant (His & Myc... | |||
TMPH-02974 | Von Willebrand Factor/vWF Protein, Mouse, Recombinant (His & Myc) | Mouse | E. coli |
Important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GP... | |||
------------------------ More ------------------------ |
Cat No. | Product Name | ||
---|---|---|---|
L7000 | Bioactive Lipid Compound Library | 385 compounds | |
A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, ... | |||
L1380 | Transcription Factor-Targeted Compound Library | 695 compounds | |
Well-chosen 695 compounds with unique structures targeting transcription factor; | |||
L4000 | Bioactive Compound Library | 14439 compounds | |
A collection of 14439 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification; | |||
L2160 | Anti-Cancer Active Compound Library | 3188 compounds | |
A unique collection of 3188 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L4150 | Featured Novel Bioactive Compound Library | 989 compounds | |
It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consis... | |||
L9850 | Orally Active Compound Library | 2427 compounds | |
A unique collection of 2427 of orally active compounds for high-throughput screening and high-content screening. | |||
L9820 | Beta-Lactam Compound Library | 97 compounds | |
A unique collection of 97 beta-lactam compounds, can be used in HTS and HCS; | |||
L4520 | Anti-Bacterial Compound Library | 904 compounds | |
A unique collection of 904 antibacterial bioactive compounds, a powerful tool for antibacterial drug development; | |||
L9900 | Inactive Ingredient Library | 182 compounds | |
A Collection of 182 inactive ingredients from FDA-approved drugs. | |||
L4010 | Bioactive Compounds Library Max | 22555 compounds | |
A collection of 22555 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification. | |||
L7300 | Potassium Channel Blocker Library | 152 compounds | |
A unique collection of 152 potassium channel blockers and agonists for high throughput and high content screening; | |||
L6610 | Anti-infective Natural Product Library | 1060 compounds | |
A unique collection of 1060 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS); | |||
L4710 | Nonsteroidal Anti-Inflammatory Compound Library | 521 compounds | |
521 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening. | |||
L3500 | Histone Modification Compound Library | 469 compounds | |
A unique collection of 469 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L1600 | Kinase Inhibitor Library | 2700 compounds | |
A unique collection of 2700 kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases; | |||
L1610 | FDA-Approved Kinase Inhibitor Library | 263 compounds | |
A unique collection of 263 kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening. | |||
L3600 | Cytokine Inhibitor Library | 604 compounds | |
A unique collection of 604 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery; | |||
L1110 | Microtubule-Targeted Compound Library | 142 compounds | |
A unique collection of 142 microtubule-targeted compounds can be used in HTS and HCS; | |||
L6730 | Anti-virus Traditional Chinese Medicine Monomer Library | 268 compounds | |
A collection of 268 TCM monomers with anti-virus activity. An effective tool for drug development and pharmacological studies. | |||
L5300 | Mitochondria-Targeted Compound Library | 812 compounds | |
A unique collection of 812 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine; | |||
L9830 | Anti-Parkinson's Disease Compound Library | 857 compounds | |
A unique collection of 857 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS. | |||
L2610 | Neurotransmitter Receptor Compound Library | 1513 compounds | |
A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening; | |||
L2010 | Highly Selective Inhibitor Library | 575 compounds | |
A collection of 575 highly selective inhibitors | |||
L4020 | NO PAINS Compound Library | 9384 compounds | |
TargetMol created the L4020 NO-PAINS Compound Library that applied the PAINS filter, remaining 9384 small molecules that are suitable for new drug development, signaling pathway research, drug repurposing and other resea... | |||
L2170 | Immuno-Oncology Compound Library | 449 compounds | |
A unique collection of 449 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening; | |||
L7110 | Anti-Hypertension Compound Library | 678 compounds | |
678 hypertension-related small molecules for high-throughput and high-content screening. |